The Barclays share price is up 60% but still looks dirt cheap with a P/E of 8.3!

Harvey Jones assumed the Barclays share price would be really expensive after its recent surge but reckons it still offers plenty of value.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

UK coloured flags waving above large crowd on a stadium sport match.

Image source: Getty Images

The Barclays (LSE: BARC) share price has been on a tear over the last year, rising 59.88%. I can’t say I’m surprised.

Last year I decided the big FTSE 100 banks were due a re-rating and snapped up shares in Lloyds Banking Group. Lloyds has done well too, up 41.64% in 12 months. Just not as well as Barclays.

While Lloyds focused on UK personal and small business banking after the financial crisis, Barclays held on to its investment banking arm. That makes it more of a freewheeling swashbuckler than stay-at-home Lloyds. It also means there’s room for both in my portfolio, as the risks and rewards balance nicely. But have I left it too late to buy Barclays?

FTSE 100 banks are flying

Today’s price-to-earnings (P/E) valuation of 8.13 suggests its shares are still good value. That’s well below the FTSE 100 average of 15.3. I’m surprised it’s so cheap, but then its P/E fell as low as 4 or 5 last year. That looked crazy at the time, even crazier today.

Barclays’ price-to-book ratio is just 0.5, just half the figure of 1 that’s usually seen as fair value. This stock is still cheap.

It posted full-year pre-tax profit of £6.55bn in 2023. That’s a lot of money, but was down from £7.01bn the year before.

The firm’s return on tangible equity (RoTE) also dipped in 2023, from 10.4% to 9%, while earnings per share (EPS) fell from 30.8p to 27.7p.

The downwards trend continued in the first half of 2024. Pre-tax profits dipped from £4.56bn to £4.22bn, while RoTE fell from 13.2% to 11.1%. EPS also retreated, from 19.9p to 18.6p. In previous years, Barclays would have been punished for that kind of slippage, but sentiment is far more positive today.

It helped that Barclays lifted guidance for full-year group net interest income, boosted by interest rates staying higher for longer. Higher rates widen net interest margins, the difference between what banks pay savers and charge borrowers.

Dividend income and growth

Barclays further cheered investors by completing a £1bn share buyback and announcing a further £750m. It also hiked its half-year dividend from 2.7p to 2.9p per share.

As Barclays shares rocket, the dividend yield has slumped to a modest 3.5%. That’s below the FTSE 100 average of 3.83%. Its yield is forecast to climb steadily though, hitting 3.72% this year and 4.03% in 2025.

A key concern is that net interest margins will be squeezed when central bankers start slashing interest rates further. That process has started and could accelerate if the US Federal Reserve cuts aggressively to avert recession.

Barclays is also under constant pressure from campaigners, who accuse it of everything from funding fossil fuels to unfairly profiting from higher interest rates. A windfall tax remains a low-level threat. A global economic slowdown a bigger one.

I’d love to hold Barclays shares but I’m always wary of buying a stock on the back of such a strong run. Usually, the good times end when I hop on board. So I’ll wait for a market wobble, and look to buy on a dip.

Harvey Jones has positions in Lloyds Banking Group Plc. The Motley Fool UK has recommended Barclays Plc and Lloyds Banking Group Plc. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Middle-aged white man pulling an aggrieved face while looking at a screen
Market Movers

Down 7%! Why on earth are Imperial Brands shares plummeting today?

Imperial Brands shares are in freefall after a negative reception to fresh trading news. Is the party finally over for…

Read more »

Rear View Of Woman Holding Man Hand during travel in cappadocia
Investing Articles

With a P/E under 7, this value stock looks far too cheap at 101p

This writer reckons value stock Hostelworld (LSE:HSW) looks dirt-cheap as it gets dividends flowing again and builds a social travel…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Investing For Beginners

Down 30% in 6 months, I think there’s a big catch to this insanely cheap stock

Jon Smith talks through why careful research is needed when trying to assess if a cheap stock is worth buying…

Read more »

Investing Articles

£5,000 invested in National Grid shares 5 years ago is now worth…

Andrew Mackie takes a closer look at National Grid shares and why short-term market weakness could be missing a powerful…

Read more »

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

How big does an ISA need to be to aim for a £1,500 monthly second income?

Harvey Jones shows how building a balanced portfolio of FTSE 100 dividend stocks can produce a high-and-rising second income in…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

£20,000 invested in BP shares 1 year ago is now worth…

BP shares have rocketed in the past 12 months, yet analysts think the real growth story is only just beginning,…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

A 6.8% forecast yield! 1 often-overlooked FTSE 100 income stock to buy today?

This income stock offers a high forecast yield and strengthening momentum, yet many investors overlook it — creating a rare…

Read more »

GSK scientist holding lab syringe
Investing Articles

GSK’s share price is under £22, but with a ‘fair value’ much higher, is it time for me to buy more right now? 

GSK’s share price rose over the last year, but a huge gap remains between its price and fair value —…

Read more »